Scientists have developed a hydrogel “rest stop” that shields cancer-fighting T cells, delaying their exhaustion and boosting ...

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors ...

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...

Immune checkpoint blockade (ICB) therapies have revolutionized cancer treatment, yet many tumors remain resistant. Now, ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

A Japanese research team led by the National Cancer Center Japan announced in the British journal Nature on June 14 that it ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some cancer cells ...

“Health policies expanding access to insurance coverage options and making new treatments more affordable are needed,” Zhao ...

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some cancer cells ...

The National Cancer Institute has terminated funds nationwide for research to fight the disease, expand care, and train new ...